ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Nifedipine Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-2B7856
Home | Market Reports | Health| Health Conditions| Heart & Hypertension
Global Nifedipine Market Insights and Forecast to 2028
BUY CHAPTERS

Global Nifedipine Market Research Report 2025

Code: QYRE-Auto-2B7856
Report
September 2025
Pages:94
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Bayer
Actavis
TEVA
Pfizer Inc
Shyndec
Huanghai
Yabao
Lifeon Pharmaceutical
ApicHope
Simcere
Honglin Pharmaceutical
EASEHEAL Pharmaceutical

Nifedipine Market Size

The global market for Nifedipine was valued at US$ 1172 million in the year 2024 and is projected to reach a revised size of US$ 1981 million by 2031, growing at a CAGR of 7.9% during the forecast period.

Nifedipine Market

Nifedipine Market

Nifedipine is a drug that belongs to the class of calcium channel blocker, which interrupts the movement of calcium in the walls of the arteries. 
The nifedipine market based on geography can be further segmented into North America, Europe, Asia Pacific, South America, and Rest of the World. North America will account for the largest share in 2022. The growth of this segment is due to factors such as widespread obesity among the American public leading to increased ailments such as heart disease, angina, hypertension, etc. In 2021, the United States leads every other country on earth in obesity rates. Approximately 36.20% of adults in the United States face overweight issues, which leads the calcium channel blocker drugs market.
However, Asia Pacific is expected to be the fastest growing segment. This growth is due to the increasing elderly population, especially in countries like India and China, the rise in chronic diseases, and the continuous improvement of medical infrastructure as governments allocate countless funds for development.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Nifedipine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nifedipine.
The Nifedipine market size, estimations, and forecasts are provided in terms of sales volume (MT) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Nifedipine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Nifedipine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Nifedipine Market Report

Report Metric Details
Report Name Nifedipine Market
Accounted market size in year US$ 1172 million
Forecasted market size in 2031 US$ 1981 million
CAGR 7.9%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • Hypertension
  • Heart Disease
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Bayer, Actavis, Teva, Pfizer, Shyndec, Honglin Pharmaceutical, Huanghai, Yabao, Lifeon Pharmaceutical, EASEHEAL Pharmaceutical, ApicHope, Simcere
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Nifedipine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Nifedipine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Nifedipine Market growing?

Ans: The Nifedipine Market witnessing a CAGR of 7.9% during the forecast period 2025-2031.

What is the Nifedipine Market size in 2031?

Ans: The Nifedipine Market size in 2031 will be US$ 1981 million.

What is the Nifedipine Market share by region?

Ans: Approximately 36.20% of adults in the United States face overweight issues, which leads the calcium channel blocker drugs market.

Who are the main players in the Nifedipine Market report?

Ans: The main players in the Nifedipine Market are Bayer, Actavis, Teva, Pfizer, Shyndec, Honglin Pharmaceutical, Huanghai, Yabao, Lifeon Pharmaceutical, EASEHEAL Pharmaceutical, ApicHope, Simcere

What are the Application segmentation covered in the Nifedipine Market report?

Ans: The Applications covered in the Nifedipine Market report are Hypertension, Heart Disease, Other

What are the Type segmentation covered in the Nifedipine Market report?

Ans: The Types covered in the Nifedipine Market report are Nifedipine Controlled Release Tablets, Nifedipine Extended Action Tablets

Recommended Reports

Cardiovascular Drugs

Hypertension Treatments

Calcium Channel Agents

1 Nifedipine Market Overview
1.1 Product Definition
1.2 Nifedipine by Type
1.2.1 Global Nifedipine Market Value Comparison by Type (2024 VS 2031)
1.2.2 Nifedipine Controlled Release Tablets
1.2.3 Nifedipine Extended Action Tablets
1.3 Nifedipine by Application
1.3.1 Global Nifedipine Market Value by Application (2024 VS 2031)
1.3.2 Hypertension
1.3.3 Heart Disease
1.3.4 Other
1.4 Global Nifedipine Market Size Estimates and Forecasts
1.4.1 Global Nifedipine Revenue 2020-2031
1.4.2 Global Nifedipine Sales 2020-2031
1.4.3 Global Nifedipine Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Nifedipine Market Competition by Manufacturers
2.1 Global Nifedipine Sales Market Share by Manufacturers (2020-2025)
2.2 Global Nifedipine Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Nifedipine Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Nifedipine, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Nifedipine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Nifedipine, Product Type & Application
2.7 Global Key Manufacturers of Nifedipine, Date of Enter into This Industry
2.8 Global Nifedipine Market Competitive Situation and Trends
2.8.1 Global Nifedipine Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Nifedipine Players Market Share by Revenue
2.8.3 Global Nifedipine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Nifedipine Market Scenario by Region
3.1 Global Nifedipine Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Nifedipine Sales by Region: 2020-2031
3.2.1 Global Nifedipine Sales by Region: 2020-2025
3.2.2 Global Nifedipine Sales by Region: 2026-2031
3.3 Global Nifedipine Revenue by Region: 2020-2031
3.3.1 Global Nifedipine Revenue by Region: 2020-2025
3.3.2 Global Nifedipine Revenue by Region: 2026-2031
3.4 North America Nifedipine Market Facts & Figures by Country
3.4.1 North America Nifedipine Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Nifedipine Sales by Country (2020-2031)
3.4.3 North America Nifedipine Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Nifedipine Market Facts & Figures by Country
3.5.1 Europe Nifedipine Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Nifedipine Sales by Country (2020-2031)
3.5.3 Europe Nifedipine Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Nifedipine Market Facts & Figures by Region
3.6.1 Asia Pacific Nifedipine Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Nifedipine Sales by Region (2020-2031)
3.6.3 Asia Pacific Nifedipine Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Nifedipine Market Facts & Figures by Country
3.7.1 Latin America Nifedipine Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Nifedipine Sales by Country (2020-2031)
3.7.3 Latin America Nifedipine Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Nifedipine Market Facts & Figures by Country
3.8.1 Middle East and Africa Nifedipine Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Nifedipine Sales by Country (2020-2031)
3.8.3 Middle East and Africa Nifedipine Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Nifedipine Sales by Type (2020-2031)
4.1.1 Global Nifedipine Sales by Type (2020-2025)
4.1.2 Global Nifedipine Sales by Type (2026-2031)
4.1.3 Global Nifedipine Sales Market Share by Type (2020-2031)
4.2 Global Nifedipine Revenue by Type (2020-2031)
4.2.1 Global Nifedipine Revenue by Type (2020-2025)
4.2.2 Global Nifedipine Revenue by Type (2026-2031)
4.2.3 Global Nifedipine Revenue Market Share by Type (2020-2031)
4.3 Global Nifedipine Price by Type (2020-2031)
5 Segment by Application
5.1 Global Nifedipine Sales by Application (2020-2031)
5.1.1 Global Nifedipine Sales by Application (2020-2025)
5.1.2 Global Nifedipine Sales by Application (2026-2031)
5.1.3 Global Nifedipine Sales Market Share by Application (2020-2031)
5.2 Global Nifedipine Revenue by Application (2020-2031)
5.2.1 Global Nifedipine Revenue by Application (2020-2025)
5.2.2 Global Nifedipine Revenue by Application (2026-2031)
5.2.3 Global Nifedipine Revenue Market Share by Application (2020-2031)
5.3 Global Nifedipine Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Bayer
6.1.1 Bayer Company Information
6.1.2 Bayer Description and Business Overview
6.1.3 Bayer Nifedipine Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Bayer Nifedipine Product Portfolio
6.1.5 Bayer Recent Developments/Updates
6.2 Actavis
6.2.1 Actavis Company Information
6.2.2 Actavis Description and Business Overview
6.2.3 Actavis Nifedipine Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Actavis Nifedipine Product Portfolio
6.2.5 Actavis Recent Developments/Updates
6.3 Teva
6.3.1 Teva Company Information
6.3.2 Teva Description and Business Overview
6.3.3 Teva Nifedipine Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Teva Nifedipine Product Portfolio
6.3.5 Teva Recent Developments/Updates
6.4 Pfizer
6.4.1 Pfizer Company Information
6.4.2 Pfizer Description and Business Overview
6.4.3 Pfizer Nifedipine Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Pfizer Nifedipine Product Portfolio
6.4.5 Pfizer Recent Developments/Updates
6.5 Shyndec
6.5.1 Shyndec Company Information
6.5.2 Shyndec Description and Business Overview
6.5.3 Shyndec Nifedipine Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Shyndec Nifedipine Product Portfolio
6.5.5 Shyndec Recent Developments/Updates
6.6 Honglin Pharmaceutical
6.6.1 Honglin Pharmaceutical Company Information
6.6.2 Honglin Pharmaceutical Description and Business Overview
6.6.3 Honglin Pharmaceutical Nifedipine Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Honglin Pharmaceutical Nifedipine Product Portfolio
6.6.5 Honglin Pharmaceutical Recent Developments/Updates
6.7 Huanghai
6.7.1 Huanghai Company Information
6.7.2 Huanghai Description and Business Overview
6.7.3 Huanghai Nifedipine Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Huanghai Nifedipine Product Portfolio
6.7.5 Huanghai Recent Developments/Updates
6.8 Yabao
6.8.1 Yabao Company Information
6.8.2 Yabao Description and Business Overview
6.8.3 Yabao Nifedipine Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Yabao Nifedipine Product Portfolio
6.8.5 Yabao Recent Developments/Updates
6.9 Lifeon Pharmaceutical
6.9.1 Lifeon Pharmaceutical Company Information
6.9.2 Lifeon Pharmaceutical Description and Business Overview
6.9.3 Lifeon Pharmaceutical Nifedipine Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Lifeon Pharmaceutical Nifedipine Product Portfolio
6.9.5 Lifeon Pharmaceutical Recent Developments/Updates
6.10 EASEHEAL Pharmaceutical
6.10.1 EASEHEAL Pharmaceutical Company Information
6.10.2 EASEHEAL Pharmaceutical Description and Business Overview
6.10.3 EASEHEAL Pharmaceutical Nifedipine Sales, Revenue and Gross Margin (2020-2025)
6.10.4 EASEHEAL Pharmaceutical Nifedipine Product Portfolio
6.10.5 EASEHEAL Pharmaceutical Recent Developments/Updates
6.11 ApicHope
6.11.1 ApicHope Company Information
6.11.2 ApicHope Description and Business Overview
6.11.3 ApicHope Nifedipine Sales, Revenue and Gross Margin (2020-2025)
6.11.4 ApicHope Nifedipine Product Portfolio
6.11.5 ApicHope Recent Developments/Updates
6.12 Simcere
6.12.1 Simcere Company Information
6.12.2 Simcere Description and Business Overview
6.12.3 Simcere Nifedipine Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Simcere Nifedipine Product Portfolio
6.12.5 Simcere Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Nifedipine Industry Chain Analysis
7.2 Nifedipine Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Nifedipine Production Mode & Process Analysis
7.4 Nifedipine Sales and Marketing
7.4.1 Nifedipine Sales Channels
7.4.2 Nifedipine Distributors
7.5 Nifedipine Customer Analysis
8 Nifedipine Market Dynamics
8.1 Nifedipine Industry Trends
8.2 Nifedipine Market Drivers
8.3 Nifedipine Market Challenges
8.4 Nifedipine Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Bayer
Actavis
TEVA
Pfizer Inc
Shyndec
Huanghai
Yabao
Lifeon Pharmaceutical
ApicHope
Simcere
Honglin Pharmaceutical
EASEHEAL Pharmaceutical
List of Tables
 Table 1. Global Nifedipine Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Nifedipine Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Nifedipine Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Nifedipine Sales (MT) of Key Manufacturers (2020-2025)
 Table 5. Global Nifedipine Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Nifedipine Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Nifedipine Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Nifedipine Average Price (USD/Kg) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Nifedipine, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Nifedipine, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Nifedipine, Product Type & Application
 Table 12. Global Key Manufacturers of Nifedipine, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Nifedipine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nifedipine as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Nifedipine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Nifedipine Sales by Region (2020-2025) & (MT)
 Table 18. Global Nifedipine Sales Market Share by Region (2020-2025)
 Table 19. Global Nifedipine Sales by Region (2026-2031) & (MT)
 Table 20. Global Nifedipine Sales Market Share by Region (2026-2031)
 Table 21. Global Nifedipine Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Nifedipine Revenue Market Share by Region (2020-2025)
 Table 23. Global Nifedipine Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Nifedipine Revenue Market Share by Region (2026-2031)
 Table 25. North America Nifedipine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Nifedipine Sales by Country (2020-2025) & (MT)
 Table 27. North America Nifedipine Sales by Country (2026-2031) & (MT)
 Table 28. North America Nifedipine Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Nifedipine Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Nifedipine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Nifedipine Sales by Country (2020-2025) & (MT)
 Table 32. Europe Nifedipine Sales by Country (2026-2031) & (MT)
 Table 33. Europe Nifedipine Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Nifedipine Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Nifedipine Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Nifedipine Sales by Region (2020-2025) & (MT)
 Table 37. Asia Pacific Nifedipine Sales by Region (2026-2031) & (MT)
 Table 38. Asia Pacific Nifedipine Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Nifedipine Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Nifedipine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Nifedipine Sales by Country (2020-2025) & (MT)
 Table 42. Latin America Nifedipine Sales by Country (2026-2031) & (MT)
 Table 43. Latin America Nifedipine Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Nifedipine Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Nifedipine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Nifedipine Sales by Country (2020-2025) & (MT)
 Table 47. Middle East and Africa Nifedipine Sales by Country (2026-2031) & (MT)
 Table 48. Middle East and Africa Nifedipine Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Nifedipine Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Nifedipine Sales (MT) by Type (2020-2025)
 Table 51. Global Nifedipine Sales (MT) by Type (2026-2031)
 Table 52. Global Nifedipine Sales Market Share by Type (2020-2025)
 Table 53. Global Nifedipine Sales Market Share by Type (2026-2031)
 Table 54. Global Nifedipine Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Nifedipine Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Nifedipine Revenue Market Share by Type (2020-2025)
 Table 57. Global Nifedipine Revenue Market Share by Type (2026-2031)
 Table 58. Global Nifedipine Price (USD/Kg) by Type (2020-2025)
 Table 59. Global Nifedipine Price (USD/Kg) by Type (2026-2031)
 Table 60. Global Nifedipine Sales (MT) by Application (2020-2025)
 Table 61. Global Nifedipine Sales (MT) by Application (2026-2031)
 Table 62. Global Nifedipine Sales Market Share by Application (2020-2025)
 Table 63. Global Nifedipine Sales Market Share by Application (2026-2031)
 Table 64. Global Nifedipine Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Nifedipine Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Nifedipine Revenue Market Share by Application (2020-2025)
 Table 67. Global Nifedipine Revenue Market Share by Application (2026-2031)
 Table 68. Global Nifedipine Price (USD/Kg) by Application (2020-2025)
 Table 69. Global Nifedipine Price (USD/Kg) by Application (2026-2031)
 Table 70. Bayer Company Information
 Table 71. Bayer Description and Business Overview
 Table 72. Bayer Nifedipine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
 Table 73. Bayer Nifedipine Product
 Table 74. Bayer Recent Developments/Updates
 Table 75. Actavis Company Information
 Table 76. Actavis Description and Business Overview
 Table 77. Actavis Nifedipine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
 Table 78. Actavis Nifedipine Product
 Table 79. Actavis Recent Developments/Updates
 Table 80. Teva Company Information
 Table 81. Teva Description and Business Overview
 Table 82. Teva Nifedipine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
 Table 83. Teva Nifedipine Product
 Table 84. Teva Recent Developments/Updates
 Table 85. Pfizer Company Information
 Table 86. Pfizer Description and Business Overview
 Table 87. Pfizer Nifedipine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
 Table 88. Pfizer Nifedipine Product
 Table 89. Pfizer Recent Developments/Updates
 Table 90. Shyndec Company Information
 Table 91. Shyndec Description and Business Overview
 Table 92. Shyndec Nifedipine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
 Table 93. Shyndec Nifedipine Product
 Table 94. Shyndec Recent Developments/Updates
 Table 95. Honglin Pharmaceutical Company Information
 Table 96. Honglin Pharmaceutical Description and Business Overview
 Table 97. Honglin Pharmaceutical Nifedipine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
 Table 98. Honglin Pharmaceutical Nifedipine Product
 Table 99. Honglin Pharmaceutical Recent Developments/Updates
 Table 100. Huanghai Company Information
 Table 101. Huanghai Description and Business Overview
 Table 102. Huanghai Nifedipine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
 Table 103. Huanghai Nifedipine Product
 Table 104. Huanghai Recent Developments/Updates
 Table 105. Yabao Company Information
 Table 106. Yabao Description and Business Overview
 Table 107. Yabao Nifedipine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
 Table 108. Yabao Nifedipine Product
 Table 109. Yabao Recent Developments/Updates
 Table 110. Lifeon Pharmaceutical Company Information
 Table 111. Lifeon Pharmaceutical Description and Business Overview
 Table 112. Lifeon Pharmaceutical Nifedipine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
 Table 113. Lifeon Pharmaceutical Nifedipine Product
 Table 114. Lifeon Pharmaceutical Recent Developments/Updates
 Table 115. EASEHEAL Pharmaceutical Company Information
 Table 116. EASEHEAL Pharmaceutical Description and Business Overview
 Table 117. EASEHEAL Pharmaceutical Nifedipine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
 Table 118. EASEHEAL Pharmaceutical Nifedipine Product
 Table 119. EASEHEAL Pharmaceutical Recent Developments/Updates
 Table 120. ApicHope Company Information
 Table 121. ApicHope Description and Business Overview
 Table 122. ApicHope Nifedipine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
 Table 123. ApicHope Nifedipine Product
 Table 124. ApicHope Recent Developments/Updates
 Table 125. Simcere Company Information
 Table 126. Simcere Description and Business Overview
 Table 127. Simcere Nifedipine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
 Table 128. Simcere Nifedipine Product
 Table 129. Simcere Recent Developments/Updates
 Table 130. Key Raw Materials Lists
 Table 131. Raw Materials Key Suppliers Lists
 Table 132. Nifedipine Distributors List
 Table 133. Nifedipine Customers List
 Table 134. Nifedipine Market Trends
 Table 135. Nifedipine Market Drivers
 Table 136. Nifedipine Market Challenges
 Table 137. Nifedipine Market Restraints
 Table 138. Research Programs/Design for This Report
 Table 139. Key Data Information from Secondary Sources
 Table 140. Key Data Information from Primary Sources
 Table 141. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Nifedipine
 Figure 2. Global Nifedipine Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Nifedipine Market Share by Type: 2024 & 2031
 Figure 4. Nifedipine Controlled Release Tablets Product Picture
 Figure 5. Nifedipine Extended Action Tablets Product Picture
 Figure 6. Global Nifedipine Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Nifedipine Market Share by Application: 2024 & 2031
 Figure 8. Hypertension
 Figure 9. Heart Disease
 Figure 10. Other
 Figure 11. Global Nifedipine Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Nifedipine Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Nifedipine Sales (2020-2031) & (MT)
 Figure 14. Global Nifedipine Average Price (USD/Kg) & (2020-2031)
 Figure 15. Nifedipine Report Years Considered
 Figure 16. Nifedipine Sales Share by Manufacturers in 2024
 Figure 17. Global Nifedipine Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Nifedipine Players: Market Share by Revenue in Nifedipine in 2024
 Figure 19. Nifedipine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Nifedipine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Nifedipine Sales Market Share by Country (2020-2031)
 Figure 22. North America Nifedipine Revenue Market Share by Country (2020-2031)
 Figure 23. U.S. Nifedipine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Nifedipine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Nifedipine Sales Market Share by Country (2020-2031)
 Figure 26. Europe Nifedipine Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Nifedipine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Nifedipine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Nifedipine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Nifedipine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Nifedipine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Nifedipine Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Nifedipine Revenue Market Share by Region (2020-2031)
 Figure 34. China Nifedipine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Nifedipine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Nifedipine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Nifedipine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Nifedipine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Taiwan Nifedipine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Indonesia Nifedipine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Thailand Nifedipine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Malaysia Nifedipine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Philippines Nifedipine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Latin America Nifedipine Sales Market Share by Country (2020-2031)
 Figure 45. Latin America Nifedipine Revenue Market Share by Country (2020-2031)
 Figure 46. Mexico Nifedipine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Brazil Nifedipine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Argentina Nifedipine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Middle East and Africa Nifedipine Sales Market Share by Country (2020-2031)
 Figure 50. Middle East and Africa Nifedipine Revenue Market Share by Country (2020-2031)
 Figure 51. Turkey Nifedipine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Saudi Arabia Nifedipine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. U.A.E Nifedipine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Global Sales Market Share of Nifedipine by Type (2020-2031)
 Figure 55. Global Revenue Market Share of Nifedipine by Type (2020-2031)
 Figure 56. Global Nifedipine Price (USD/Kg) by Type (2020-2031)
 Figure 57. Global Sales Market Share of Nifedipine by Application (2020-2031)
 Figure 58. Global Revenue Market Share of Nifedipine by Application (2020-2031)
 Figure 59. Global Nifedipine Price (USD/Kg) by Application (2020-2031)
 Figure 60. Nifedipine Value Chain
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS

Global Nifedipine Medication Market Research Report 2024
Global Nifedipine Injection Market Research Report 2025
Global Diltiazem Calcium Channel Blocker Market Research Report 2025
Global Verapamil Calcium Channel Blocker Market Research Report 2025
Global Nifedipine Tablets Market Research Report 2024
Global Calcium Channel Antagonist Market Research Report 2024
Diltiazem Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Nicardipine Hydrochloride Tablets Market Research Report 2025
Global Nilvadipine Market Research Report 2024
Global Amlodipine Besilate Market Research Report 2024
Global Felodipine Tablets Market Research Report 2025
Global Diltiazem Hydrochloride Tablets Market Research Report 2025
Global Calcium Channel Modulators Market Research Report 2024
Global Calcium Channel Blocker Sales Market Report Competitive Analysis and Regional Opportunities 2025 2031
Global Verapamil Market Research Report 2024
Global Nicardipine Hydrochloride Injection Market Research Report 2024
Calcium Channel Blockers Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Antihypertensive Drugs Market Research Report 2024
Global Azelnidipine API Market Research Report 2025
Global Nifedipine API Market Research Report 2025
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions